September 1986
Volume 27, Issue 9
Articles  |   September 1986
Monoclonal antibodies to human primary uveal melanomas demonstrate tumor heterogeneity.
Investigative Ophthalmology & Visual Science September 1986, Vol.27, 1362-1367. doi:
  • Views
  • PDF
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      B E Damato, A M Campbell, B J McGuire, W R Lee, W S Foulds; Monoclonal antibodies to human primary uveal melanomas demonstrate tumor heterogeneity.. Invest. Ophthalmol. Vis. Sci. 1986;27(9):1362-1367. doi:

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements
This content is PDF only. Please click on the PDF icon to access.

Five rat monoclonal antibodies to human uveal melanoma were produced using primary tumor tissue for immunization and screening. These monoclonal antibodies were tested by enzyme-linked immunosorbent assay against 12 uveal melanomas, one breast carcinoma, and peripheral blood lymphocytes from five healthy volunteers. One monoclonal antibody, 4A3, reacted against all the melanomas and none of the controls. On immunoblotting, this monoclonal antibody identified a protein doublet in the molecular weight range 55,000. With these monoclonal antibodies, it was possible to demonstrate significant variation in the antigenic profiles of the uveal melanomas which was not present in the controls.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.